HIV感染者克隆性造血的流行病学与临床影响
基于瑞士HIV队列研究约2500例HIV感染者,采用深度靶向测序检测CHIP基因及全基因组基因分型检测mCAs,发现CHIP占25%、mCAs占16%,二者随年龄增长且常共现,与全因死亡率、血液恶性肿瘤及炎症状态指标相关。
要点
- HIV感染者中CHIP占25%、mCAs占16%,均随年龄增长且常共现。
- CHIP与全因死亡(HR=1.3)及髓系肿瘤风险(HR=9.4)相关。
- CHIP与mCAs共现时淋系肿瘤风险HR>20。
核心结论
- HIV感染者中克隆性造血常见,CHIP与mCAs共现及慢性免疫激活可能参与其发生与临床后果。
研究设计与样本
- 基于瑞士HIV队列研究约2500例HIV感染者,采用CHIP基因深度靶向测序和全基因组基因分型检测mCAs,分析CH患病率、克隆大小及与临床变量的关联。
主要发现
- CHIP占25%,mCAs占16%,二者与年龄正相关。
- 常染色体mCAs与CHIP共现OR=1.7,p=0.02。
- CHIP与全因死亡HR=1.3,p=0.02。
- CHIP对髓系肿瘤风险HR=9.4,p=0.01。
- CHIP与mCAs共现对淋系肿瘤风险HR>20,p<0.001。
临床怎么用
- 对HIV感染者应关注克隆性造血,尤其高龄及炎症指标异常者,可能提示死亡及血液肿瘤风险增高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clonal hematopoiesis (CH), defined by the expansion of hematopoietic cells with somatic mutations in leukemogenic genes (CH of indeterminate potential (CHIP)) or with mosaic chromosomal alterations (mCAs), is associated with aging and adverse health outcomes in the general population. CHIP prevalence is higher in People with HIV (PWH) than in controls. However, the full spectrum, prevalence, and clinical consequences of CH in PWH remain incompletely understood. METHODS: We assessed CHIP and mCAs in a large sample of PWH (N∼2,500) from the Swiss HIV Cohort Study. Using high-depth targeted sequencing of CHIP genes and genome-wide genotyping to call mCAs, we quantified the prevalence and clone size of both CH types and investigated an association of CH with clinical variables. RESULTS: CHIP (25% of individuals) and mCAs (16% of individuals) were common, positively correlated with age, often co-occurring (OR=1.7, p=0.02 for autosomal mCAs), and associated with various clinical outcomes, including all-cause mortality (HR=1.3, p=0.02 for CHIP) and hematologic malignancies (HR=9.4, p=0.01 for the effect of CHIP on the risk of myeloid cancer; HR>20, p<0.001 for the effect of co-occurring CHIP and mCAs on the risk of lymphoid cancer). We also observed associations of CH with several proxies of inflammatory status (CD4:CD8 ratio, HIV viral load, late initiation of antiretroviral therapy, and toxicity of antiretroviral drugs). CONCLUSION: The study provides a comprehensive assessment of the CH landscape in PWH, highlighting potential causes and consequences in this population and suggesting an interaction between CH and chronic immune activation.
引用
- Timonina V, Popadin K, Ait Oumelloul M, et al. Epidemiology and Clinical Impact of Clonal Hematopoiesis in People with HIV. J Infect Dis. 2026. PMID: 42518217. doi:10.1093/infdis/jiag393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。